MedTrace Logo

Pulmonary Microbiota and ARDS Mortality

NCT04133558 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2019-11-01

No results posted yet for this study

Summary

Acute respiratory distress syndrome (ARDS) is due to diffuse and severe lung inflammation. Despite intensive research, few therapeutics have emerged and treatment is still mostly symptomatic. As lung microbiota seems to be associated with lung inflammation in numerous chronic respiratory diseases, this study aims to analyse the correlation between lung microbiota and mortality.

Conditions

  • Acute Respiratory Distress Syndrome

Interventions

OTHER

tracheal aspirate during routine care

tracheal aspirate during routine care

Sponsors & Collaborators

  • University of Bordeaux

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-31
Primary Completion
2020-11-01
Completion
2020-11-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04133558 on ClinicalTrials.gov